The DOI matches its Crossref record; 279 of the 279 references it cites were found in a registry or an index.
Rational Design of Cancer Nanomedicine: Nanoproperty Integration and Synchronization
Abstract
Current cancer nanomedicines can only mitigate adverse effects but fail to enhance therapeutic efficacies of anticancer drugs. Rational design of next‐generation cancer nanomedicines should aim to enhance their therapeutic efficacies. Taking this into account, this review first analyzes the typical cancer‐drug‐delivery process of an intravenously administered nanomedicine and concludes that the delivery involves a five‐step CAPIR cascade and that high efficiency at every step is critical to guarantee high overall therapeutic efficiency. Further analysis shows that the nanoproperties needed in each step for a nanomedicine to maximize its efficiency are different and even opposing in different steps, particularly what the authors call the PEG, surface‐charge, size and stability dilemmas. To resolve those dilemmas in order to integrate all needed nanoproperties into one nanomedicine, stability, surface and size nanoproperty transitions (3S transitions for short) are proposed and the reported strategies to realize these transitions are comprehensively summarized. Examples of nanomedicines capable of the 3S transitions are discussed, as are future research directions to design high‐performance cancer nanomedicines and their clinical translations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–279 of 279
Jeong, J. H., Kim, S. W., & Park, T. G. (2003) · Bioconjugate Chemistry · doi:10.1021/bc025632k · Cited by 161
Liu, Y., Zhang, D., Qiao, Z., Qi, G., Liang, X., Chen, X., & Wang, H. (2015) · Advanced Materials · doi:10.1002/adma.201501502 · Cited by 157
Peng, Z., & Kopec̆ek, J. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b00922 · Cited by 151
Oishi, M., Sasaki, S., Nagasaki, Y., & Kataoka, K. (2003) · Biomacromolecules · doi:10.1021/bm034164u · Cited by 151
Eliasof, S. D., Lazarus, D. D., Peters, C. G., Case, R. I., Cole, R. O., Hwang, J., Schluep, T., Chao, J., Lin, J. L., Yen, Y., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309566110 · Cited by 147
Incio, J., Suboj, P., Chin, S. M., Vardam-Kaur, T., Liu, H., Hato, T., Babykutty, S., Chen, I. X., Deshpande, V., Jain, R. K., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141392 · Cited by 147
Ji, T., Li, S., Zhang, Y., Lang, J., Ding, Y., Zhao, X. L., Zhao, R., Li, Y., Shi, J. Y., Hao, J., et al. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b11619 · Cited by 141
Multi-stage delivery nano-particle systems for therapeutic applications
Serda, R. E., Godin, B., Blanco, E., Chiappini, C., & Mauro Ferrari, B. (2010) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2010.05.004 · Cited by 140
Milosevic, M., Fyles, A., & Hill, R. P. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00512-4 · Cited by 139
Association and Dissociation Characteristics of Polymer/DNA Complexes Used for Gene Delivery
Arigita, C., Zuidam, N. J., Crommelin, D. J. A., et al. (1999) · Pharmaceutical Research · doi:10.1023/a:1015096302720 · Cited by 135
PEG shielded MMP sensitive CPPs for efficient and tumor specific gene delivery in vivo
Veiman, K.-L., Künnapuu, K., Lehto, T., Kiisholts, K., Pärn, K., Langel, Ü., & Kurrikoff, K. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.04.038 · Cited by 135
Nuclear drug delivery for cancer chemotherapy
Sui, M., Liu, W., & Shen, Y. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.041 · Cited by 134
Self-citationThe design and development of DaunoXome® for solid tumor targeting in vivo
Forssen, E. A. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00453-x · Cited by 134
Gao, H., Xiong, Y., Zhang, S., Yang, Z. H., Cao, S., & Jiang, X. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400751g · Cited by 133
In Vivo Distribution of Polymeric Nanoparticles at the Whole-Body, Tumor, and Cellular Levels
Lee, H., Hoang, B., Fonge, H., Reilly, R. M., & Allen, C. J. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0068-z · Cited by 132
Zuo, Z.-Q., Chen, K., Yu, X., Zhao, G., Shen, S., Cao, Z., Luo, Y., Wang, Y., & Wang, J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.12.014 · Cited by 131
Rifkin, R. M., Gregory, S. A., Mohrbacher, A. M., & Hussein, M. A. (2006) · Cancer · doi:10.1002/cncr.21662 · Cited by 130
Amrite, A. C., Edelhauser, H. F., Singh, S. R., & Kompella, U. B. (2008) · PubMed Central · Cited by 125
Resistance to chemotherapy in advanced ovarian cancer: mechanisms and current strategies
Vasey, P. A. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601497 · Cited by 123
New poly(amidoamine)s containing disulfide linkages in their main chain
Emilitri, E., Ranucci, E., & Ferruti, P. (2005) · Journal of Polymer Science Part A Polymer Chemistry · doi:10.1002/pola.20599 · Cited by 122
Su, Y., Hu, Y., Du, Y., Huang, X., He, J., You, J., Yuan, H., & Hu, F. (2015) · Molecular Pharmaceutics · doi:10.1021/mp500710x · Cited by 120
Smart linkers in polymer–drug conjugates for tumor-targeted delivery
Chang, M., Zhang, F., Wei, T., Zuo, T., Guan, Y., Lin, G., & Shao, W. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1108324 · Cited by 119
Lee, J. S., Ankoné, M. J. K., Pieters, E. H. E., Schiffelers, R. M., Hennink, W. E., & Feijén, J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.028 · Cited by 118
McNeeley, K. M., Annapragada, A., & Bellamkonda, R. V. (2007) · Nanotechnology · doi:10.1088/0957-4484/18/38/385101 · Cited by 117
Cun, X., Ruan, S., Chen, J., Zhang, L., Li, J., He, Q., & Gao, H. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.12.002 · Cited by 115
Flessner, M. F., Choi, J., Credit, K., Deverkadra, R., & Henderson, K. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2332 · Cited by 114
Challenges of up-scaling lentivirus production and processing
McCarron, A., Donnelley, M., McIntyre, C., & Parsons, D. (2016) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2016.10.016 · Cited by 113
Enzyme-triggered, cell penetrating peptide-mediated delivery of anti-tumor agents
He, H., Sun, L., Ye, J., Liu, E., Chen, S., Liang, Q., Shin, M. C., & Yang, V. C.-M. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.040 · Cited by 111
Deng, X., Zheng, N., Song, Z., Yin, L., & Cheng, J. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.03.005 · Cited by 110
Cun, X., Chen, J., Ruan, S., Zhang, L., Wan, J., He, Q., & Gao, H. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b09391 · Cited by 109
A pH/Enzyme-responsive tumor-specific delivery system for doxorubicin
Dong, L., Xia, S., Wu, K., Huang, Z. D., Chen, H., Chen, J., & Zhang, J. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.04.049 · Cited by 108
Hu, Q., Rijcken, C. J. F., Bansal, R., Hennink, W. E., Storm, G., & Prakash, J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.02.085 · Cited by 106
Choi, J., Credit, K., Henderson, K., Deverkadra, R., He, Z., Wiig, H., Vanpelt, H. M., & Flessner, M. F. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2141 · Cited by 105
Charge-Reversal Polyamidoamine Dendrimer for Cascade Nuclear Drug Delivery
Shen, Y., Zhou, Z., Sui, M., Tang, J., Xu, P., Kirk, E. A. V., Murdoch, W. J., Fan, M., & Radosz, M. (2010) · Nanomedicine · doi:10.2217/nnm.10.86 · Cited by 104
Self-citationPolymer brush-stabilized polyplex for a siRNA carrier with long circulatory half-life
Sato, A., Choi, S. W., Hirai, M., Yamayoshi, A., Moriyama, R., Yamano, T., Takagi, M., Kano, A., Shimamoto, A., & Maruyama, A. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.04.018 · Cited by 103
Degradable Poly(β-amino ester) nanoparticles for cancer cytoplasmic drug delivery
Shen, Y., Tang, H., Zhan, Y., Kirk, E. A. V., & Murdoch, W. J. (2009) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2008.09.003 · Cited by 102
Self-citationShen, Y., Zhan, Y., Tang, J., Xu, P., Johnson, P. A., Radosz, M., Kirk, E. A. V., & Murdoch, W. J. (2008) · AIChE Journal · doi:10.1002/aic.11600 · Cited by 102
Self-citationThe targeted behavior of thermally responsive nanohydrogel evaluated by NIR system in mouse model
Zhang, J., Chen, H., Xu, L. S., & Gu, Y. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.07.019 · Cited by 102
Yim, H., Park, S.-J., Bae, Y. H., & Na, K. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.06.058 · Cited by 101
Zou, Z., He, X., He, D., Wang, K., Qing, Z., Yang, X., Wen, L., Xiong, J. J., Li, L., & Cai, L. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.04.034 · Cited by 101
Hama, S., Itakura, S., Nakai, M., Nakayama, K., Morimoto, S., Suzuki, S., & Kogure, K. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.011 · Cited by 101
Molecularly Precise Dendrimer–Drug Conjugates with Tunable Drug Release for Cancer Therapy
Zhou, Z., Ma, X., Murphy, C. J., et al. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201406442 · Cited by 101
Self-citationAcetal Linked Oligoethylenimines for Use As pH-Sensitive Gene Carriers
Knorr, V., Ruß, V., Allmendinger, L., Ogris, M., & Wagner, E. (2008) · Bioconjugate Chemistry · doi:10.1021/bc8001858 · Cited by 100
Translational considerations for cancer nanomedicine
Stern, S. T., Hall, J. B., Yu, L. L., Wood, L. J., Paciotti, G. F., Tamarkin, L., Long, S. E., & McNeil, S. E. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.04.008 · Cited by 99
Cai, D., Gao, W., He, B., Dai, W., Zhang, H., Wang, X., Wang, J., Zhang, X., & Zhang, Q. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.088 · Cited by 98
Han, X. F., Liu, J., Liu, M., Xie, C., Zhan, C., Gu, B., Liu, Y., Feng, L., & Lu, W. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.12.035 · Cited by 97
Hybrid Collagenase Nanocapsules for Enhanced Nanocarrier Penetration in Tumoral Tissues
Villegas, M. R., Baeza, A., & Vallet‐Regí, M. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b07116 · Cited by 95
Pharmacokinetics and biodistribution of near-infrared fluorescence polymeric nanoparticles
Yang, Z., Leon, J. W., Martin, M., Harder, J., Zhang, R., Liang, D., Lü, W., Tian, M., Gelovani, J. G., Qiao, A., et al. (2009) · Nanotechnology · doi:10.1088/0957-4484/20/16/165101 · Cited by 94
Keeney, M., Ong, S., Padilla-Lopez, A., Yao, Z., Goodman, S. B., Wu, J. C., & Yang, F. (2013) · ACS Nano · doi:10.1021/nn402657d · Cited by 91
Stabilized Nanocarriers for Plasmids Based Upon Cross-linked Poly(ethylene imine)
Neu, M., Sitterberg, J., Bakowsky, U., & Kissel, T. (2006) · Biomacromolecules · doi:10.1021/bm060788z · Cited by 88
Liang, D.-S., Su, H., Liu, Y., Wang, A.-T., & Qi, X. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.08.035 · Cited by 85
Boomer, J. A., Qualls, M. M., Inerowicz, H. D., Haynes, R. H., Patri, V. S., Kim, J.-M., & Thompson, D. H. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800239b · Cited by 84
Strategies for triggered drug release from tumor targeted liposomes
Blenke, E. O., Mastrobattista, E., & Schiffelers, R. M. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.805742 · Cited by 80
Johnson, R. N., Chu, D. S. H., Shi, J., Schellinger, J. G., Carlson, P. M., & Pun, S. H. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.009 · Cited by 79
Linderoth, L., Peters, G. H. J., Madsen, R., & Andresen, T. L. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200805241 · Cited by 79
The Role of Nanomaterials in Translational Medicine
Lavik, E., & von Recum, H. A. (2011) · ACS Nano · doi:10.1021/nn201371a · Cited by 78
Yang, J., & Kopec̆ek, J. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.013 · Cited by 78
Matrix Metalloproteinase-Assisted Triggered Release of Liposomal Contents
Sarkar, N. R., Banerjee, J., Hanson, A. J., Elegbede, A. I., Rosendahl, T., Krueger, A. B., Banerjee, A. L., Tobwala, S., Wang, R., Lu, X., et al. (2007) · Bioconjugate Chemistry · doi:10.1021/bc070081p · Cited by 74
Degradable Dual pH‐ and Temperature‐Responsive Photoluminescent Dendrimers
Shen, Y., Ma, X., Zhang, B., Zhou, Z., Sun, Q., Jin, E., Sui, M., Tang, J., Wang, J., & Fan, M. (2011) · Chemistry - A European Journal · doi:10.1002/chem.201003495 · Cited by 74
Self-citationRaghupathi, K. R., Azagarsamy, M. A., & Thayumanavan, S. (2011) · Chemistry - A European Journal · doi:10.1002/chem.201101066 · Cited by 68
2017 Clinical trials update in new treatments of β‐thalassemia
Makis, A. C., Hatzimichael, E. C., Papassotiriou, I., & Voskaridou, E. (2016) · American Journal of Hematology · doi:10.1002/ajh.24530 · Cited by 67
Malugin, A., Kopečková, P., & Kopeček, J. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.08.016 · Cited by 64
Lv, S., Song, W., Tang, Z., Li, M., Yu, H., Hong, H., & Chen, X. (2014) · Molecular Pharmaceutics · doi:10.1021/mp4007387 · Cited by 60
A cooperative polymeric platform for tumor-targeted drug delivery
Song, W., Tang, Z., Zhang, D., Li, M., Gu, J., & Chen, X. (2015) · Chemical Science · doi:10.1039/c5sc01698c · Cited by 57
Remant Bahadur, K. C., Chandrashekaran, V., Cheng, B., Chen, H., Peña, M. M. O., Zhang, J., Montgomery, J., & Xu, P. (2014) · Molecular Pharmaceutics · doi:10.1021/mp5000482 · Cited by 57
Zhou, Z., Tang, J., Sun, Q., Murdoch, W. J., & Shen, Y. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb01027f · Cited by 50
Self-citationSynthesis and characterization of HPMA copolymer–aminopropylgeldanamycin conjugates
Kasuya, Y., Lu, Z., Kopečková, P., Minko, T., Tabibi, S. E., & Kopec̆ek, J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00318-2 · Cited by 48
Emerging antitumor applications of extracellularly reengineered polymeric nanocarriers
Chen, J., Ding, J., Xiao, C., Zhuang, X., & Chen, X. (2015) · Biomaterials Science · doi:10.1039/c5bm00044k · Cited by 40
Synthesis of Degradable Functional Poly(ethylene glycol) Analogs as Versatile Drug Delivery Carriers
Wang, N., Dong, A., Tang, H., Kirk, E. A. V., Johnson, P. A., Murdoch, W. J., Radosz, M., & Shen, Y. (2007) · Macromolecular Bioscience · doi:10.1002/mabi.200700065 · Cited by 36
Self-citationTyrrell, Z. L., Shen, Y., & Radosz, M. (2011) · The Journal of Physical Chemistry C · doi:10.1021/jp202335r · Cited by 29
Self-citationCystic fibrosis gene therapy: a mutation-independent treatment
Uta Griesenbach, D., Davies, J. C., & Alton, E. W. F. W. (2016) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000327 · Cited by 28
Lee, S. Y., Park, H. S., Lee, K. Y., Kim, H. J., Jeon, Y. J., Jang, T. W., Lee, K. H., Kim, Y. C., Kim, K. S., Oh, I., et al. (2013) · Clinical Lung Cancer · doi:10.1016/j.cllc.2012.11.005 · Cited by 26
Analyzing spatiotemporal distribution of uniquely fluorescent nanoparticles in xenograft tumors
Stirland, D. L., Matsumoto, Y., Toh, K., Kataoka, K., & Bae, Y. H. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.02.016 · Cited by 25
Fabrication of dendrimer-releasing lipidic nanoassembly for cancer drug delivery
Sun, Q., Ma, X., Zhang, B., Zhou, Z., Jin, E., Shen, Y., Kirk, E. A. V., Murdoch, W. J., Radosz, M., & Sun, W. (2016) · Biomaterials Science · doi:10.1039/c6bm00189k · Cited by 25
Self-citationZhou, Z., Murdoch, W. J., & Shen, Y. (2015) · Polymer · doi:10.1016/j.polymer.2015.08.061 · Cited by 19
Self-citationZhang, L., Zhang, R., Yang, J., Wang, J., & Kopec̆ek, J. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.004 · Cited by 17
Tyrrell, Z. L., Shen, Y., & Radosz, M. (2012) · Macromolecules · doi:10.1021/ma300271k · Cited by 13
Self-citationGreen, J., Tyrrell, Z. L., & Radosz, M. (2010) · The Journal of Physical Chemistry C · doi:10.1021/jp100646a · Cited by 9
Is nanomedicine still promising?
Peiris, P. M., & Karathanasis, E. (2011) · Oncotarget · doi:10.18632/oncotarget.295 · Cited by 7
Cited by
Danaei, M., Dehghankhold, M., Ataei, S., Hasanzadeh Davarani, F., Javanmard, R., Dokhani, A., Khorasani, S., & Mozafari, M. R. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10020057 · Cited by 4,832
Reactive Oxygen Species (ROS)-Based Nanomedicine
Yang, B., Chen, Y., & Shi, J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00626 · Cited by 2,443
Nanomedicine in cancer therapy
Fan, D., Cao, Y., Cao, M., Wang, Y., Cao, Y., & Gong, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01536-y · Cited by 878
Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics
Mi, P. (2020) · Theranostics · doi:10.7150/thno.38069 · Cited by 830
Enzyme-activatable polymer–drug conjugate augments tumour penetration and treatment efficacy
Zhou, Q., Shao, S., Wang, J., Xu, C., Xiang, J., Piao, Y., Zhou, Z., Yu, Q., Tang, J., Liu, X., et al. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0485-z · Cited by 819
Self-citation
Metadata
- Authors
- Sun, Q., Zhou, Z., Qiu, N., & Shen, Y.
- Venue
- Advanced Materials
- Publisher
- Wiley
- Published
- 2017-02-24
- Volume
- 29
- Issue
- 14
- ISSN
- 0935-9648 (ISSN-L)
- 1521-4095
- OpenAlex
- W2590680367
- Cited by
- 1,058
- References
- 279
- FWCI
- 32.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.